Syquant Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Syquant Capital's PACB Position: Q3 2019 in Review
Syquant Capital sold out of Pacific Biosciences (PACB) in Q3 2019, closing a stake of 712,227 shares — an estimated $4.31M sold.
Syquant Capital first reported a position in PACB in Q1 2019 and held it in 2 quarters. The position peaked at $4.31M in Q2 2019. 148 funds tracked by Wall St. Rank hold PACB as of Q3 2019.
- Syquant Capital reported no remaining Pacific Biosciences position as of Q3 2019 after selling out during the quarter.
- Syquant Capital sold 712,227 Pacific Biosciences shares in Q3 2019, an estimated $4.31M.
- Syquant Capital first reported a position in Pacific Biosciences in Q1 2019 and held it in 2 quarters.
- Syquant Capital's Pacific Biosciences position peaked at $4.31M in Q2 2019.
- 148 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2019.
Based on Syquant Capital's 13F filing for Q3 2019, filed 17 Oct 2019.